{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T02:27:12Z","timestamp":1779244032171,"version":"3.51.4"},"reference-count":29,"publisher":"American Society for Microbiology","issue":"7","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Vaccine Immunol"],"published-print":{"date-parts":[[2010,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>Meningococcal factor H-binding protein (fHbp) is a promising antigen that is part of two vaccines in clinical development. The protein specifically binds human complement factor H (fH), which downregulates complement activation on the bacterial surface and enables the organism to evade host defenses. In humans, the vaccine antigen forms a complex with fH, which may affect anti-fHbp antibody repertoire and decrease serum bactericidal activity by covering important fHbp epitopes. In a recent study, fHbp residues in contact with fH were identified from a crystal structure. Two fHbp glutamate residues that mediated ion-pair interactions with fH were replaced with alanine, and the resulting E218A\/E239A mutant no longer bound the fH fragment. In the present study, we generated the E218A\/E239A mutant recombinant protein and confirmed the lack of fH binding. By enzyme-linked immunosorbent assay (ELISA), the mutant fHbp showed similar respective concentration-dependent inhibition of binding of four bactericidal anti-fHbp monoclonal antibodies (MAbs) to fHbp, compared with inhibition by the soluble wild-type protein. In two mouse strains, the mutant fHbp elicited up to 4-fold-lower IgG anti-fHbp antibody titers and up to 20-fold-lower serum bactericidal titers than those elicited by the wild-type fHbp vaccine. Thus, although introduction of the two alanine substitutions to eliminate fH binding did not appear to destabilize the molecule globally, the mutations resulted in decreased immunogenicity in mouse models in which neither the mutant nor the wild-type control vaccine bound fH. These results cast doubt on the vaccine potential in humans of this mutant fHbp.<\/jats:p>","DOI":"10.1128\/cvi.00103-10","type":"journal-article","created":{"date-parts":[[2010,6,3]],"date-time":"2010-06-03T02:38:53Z","timestamp":1275532733000},"page":"1074-1078","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":23,"title":["Impaired Immunogenicity of a Meningococcal Factor H-Binding Protein Vaccine Engineered To Eliminate Factor H Binding"],"prefix":"10.1128","volume":"17","author":[{"given":"Peter T.","family":"Beernink","sequence":"first","affiliation":[{"name":"Center for Immunobiology and Vaccine Development, Children's Hospital Oakland Research Institute, Oakland, California 94609"},{"name":"Division of Infectious Diseases and Immunology, University of Massachusetts Medical Center, Worcester, Massachusetts 01605"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jutamas","family":"Shaughnessy","sequence":"additional","affiliation":[{"name":"Center for Immunobiology and Vaccine Development, Children's Hospital Oakland Research Institute, Oakland, California 94609"},{"name":"Division of Infectious Diseases and Immunology, University of Massachusetts Medical Center, Worcester, Massachusetts 01605"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Ram","sequence":"additional","affiliation":[{"name":"Center for Immunobiology and Vaccine Development, Children's Hospital Oakland Research Institute, Oakland, California 94609"},{"name":"Division of Infectious Diseases and Immunology, University of Massachusetts Medical Center, Worcester, Massachusetts 01605"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan M.","family":"Granoff","sequence":"additional","affiliation":[{"name":"Center for Immunobiology and Vaccine Development, Children's Hospital Oakland Research Institute, Oakland, California 94609"},{"name":"Division of Infectious Diseases and Immunology, University of Massachusetts Medical Center, Worcester, Massachusetts 01605"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1086\/597806","volume":"199","year":"2009","unstructured":"Beernink, P. T., D. A. Caugant, J. A. Welsch, O. Koeberling, and D. M. Granoff. 2009. Meningococcal factor H-binding protein variants expressed by epidemic capsular group A, W-135, and X strains from Africa. J. Infect. Dis.199:1360-1368.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00033-08"},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1099\/mic.0.029876-0","volume":"155","year":"2009","unstructured":"Beernink, P. T., and D. M. Granoff. 2009. The modular architecture of meningococcal factor H-binding protein. Microbiology155:2873-2883.","journal-title":"Microbiology"},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/j.molimm.2009.02.021","volume":"46","year":"2009","unstructured":"Beernink, P. T., C. Lopasso, A. Angiolillo, F. Felici, and D. Granoff. 2009. A region of the N-terminal domain of meningococcal factor H-binding protein that elicits bactericidal antibody across antigenic variant groups. Mol. Immunol.46:1647-1653.","journal-title":"Mol. Immunol."},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00367-08"},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"9022","DOI":"10.1074\/jbc.C800214200","volume":"284","year":"2009","unstructured":"Cantini, F., D. Veggi, S. Dragonetti, S. Savino, M. Scarselli, G. Romagnoli, M. Pizza, L. Banci, and R. Rappuoli. 2009. Solution structure of the factor H-binding protein, a survival factor and protective antigen of Neisseria meningitidis. J. Biol. Chem.284:9022-9026.","journal-title":"J. Biol. Chem."},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1086\/649209","volume":"50","year":"2010","unstructured":"Cohn, A. C., J. R. MacNeil, L. H. Harrison, C. Hatcher, J. Theodore, M. Schmidt, T. Pondo, K. E. Arnold, J. Baumbach, N. Bennett, A. S. Craig, M. Farley, K. Gershman, S. Petit, R. Lynfield, A. Reingold, W. Schaffner, K. A. Shutt, E. R. Zell, L. W. Mayer, T. Clark, D. Stephens, and N. E. Messonnier. 2010. Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease. Clin. Infect. Dis.50:184-191.","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_2_9_2","first-page":"355","year":"1983","unstructured":"Finne, J., M. Leinonen, and P. H. Makela. 1983. Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis. Lancetii:355-357.","journal-title":"Lancet"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.72.4.2088-2100.2004"},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"10834","DOI":"10.1073\/pnas.0603940103","volume":"103","year":"2006","unstructured":"Giuliani, M. M., J. Adu-Bobie, M. Comanducci, B. Arico, S. Savino, L. Santini, B. Brunelli, S. Bambini, A. Biolchi, B. Capecchi, E. Cartocci, L. Ciucchi, F. Di Marcello, F. Ferlicca, B. Galli, E. Luzzi, V. Masignani, D. Serruto, D. Veggi, M. Contorni, M. Morandi, A. Bartalesi, V. Cinotti, D. Mannucci, F. Titta, E. Ovidi, J. A. Welsch, D. Granoff, R. Rappuoli, and M. Pizza. 2006. A universal vaccine for serogroup B meningococcus. Proc. Natl. Acad. Sci. U. S. A.103:10834-10839.","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.73.2.1151-1160.2005"},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1086\/648966","volume":"50","year":"2010","unstructured":"Granoff, D. M. 2010. Review of meningococcal group B vaccines. Clin. Infect. Dis.50(Suppl. 2):S54-S65.","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.01191-08"},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1099\/jmm.0.46288-0","volume":"55","year":"2006","unstructured":"Gray, S. J., C. L. Trotter, M. E. Ramsay, M. Guiver, A. J. Fox, R. Borrow, R. H. Mallard, and E. B. Kaczmarski. 2006. Epidemiology of meningococcal disease in England and Wales 1993\/94 to 2003\/04: contribution and experiences of the Meningococcal Reference Unit. J. Med. Microbiol.55:887-896.","journal-title":"J. Med. Microbiol."},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"e979","DOI":"10.1542\/peds.2006-0281","volume":"118","year":"2006","unstructured":"Kaplan, S. L., G. E. Schutze, J. A. Leake, W. J. Barson, N. B. Halasa, C. L. Byington, C. R. Woods, T. Q. Tan, J. A. Hoffman, E. R. Wald, K. M. Edwards, and E. O. Mason, Jr. 2006. Multicenter surveillance of invasive meningococcal infections in children. Pediatrics118:e979-e984.","journal-title":"Pediatrics"},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1086\/589308","volume":"198","year":"2008","unstructured":"Koeberling, O., A. Seubert, and D. M. Granoff. 2008. Bactericidal antibody responses elicited by a meningococcal outer membrane vesicle vaccine with overexpressed factor H-binding protein and genetically attenuated endotoxin. J. Infect. Dis.198:262-270.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"501","DOI":"10.4049\/jimmunol.177.1.501","volume":"177","year":"2006","unstructured":"Madico, G., J. A. Welsch, L. A. Lewis, A. McNaughton, D. H. Perlman, C. E. Costello, J. Ngampasutadol, U. Vogel, D. M. Granoff, and S. Ram. 2006. The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance. J. Immunol.177:501-510.","journal-title":"J. Immunol."},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"8738","DOI":"10.1074\/jbc.M808831200","volume":"284","year":"2009","unstructured":"Mascioni, A., B. E. Bentley, R. Camarda, D. A. Dilts, P. Fink, V. Gusarova, S. K. Hoiseth, J. Jacob, S. L. Lin, K. Malakian, L. K. McNeil, T. Mininni, F. Moy, E. Murphy, E. Novikova, S. Sigethy, Y. Wen, G. W. Zlotnick, and D. H. Tsao. 2009. Structural basis for the immunogenic properties of the meningococcal vaccine candidate LP2086. J. Biol. Chem.284:8738-8746.","journal-title":"J. Biol. Chem."},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1084\/jem.20021911","volume":"197","year":"2003","unstructured":"Masignani, V., M. Comanducci, M. M. Giuliani, S. Bambini, J. Adu-Bobie, B. Arico, B. Brunelli, A. Pieri, L. Santini, S. Savino, D. Serruto, D. Litt, S. Kroll, J. A. Welsch, D. M. Granoff, R. Rappuoli, and M. Pizza. 2003. Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870. J. Exp. Med.197:789-799.","journal-title":"J. Exp. Med."},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/j.vaccine.2009.12.027","volume":"28","year":"2010","unstructured":"Pajon, R., P. T. Beernink, L. H. Harrison, and D. M. Granoff. 2010. Frequency of factor H-binding protein modular groups and susceptibility to cross-reactive bactericidal activity in invasive meningococcal isolates. Vaccine28:2122-2129.","journal-title":"Vaccine"},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1126\/science.287.5459.1816","volume":"287","year":"2000","unstructured":"Pizza, M., V. Scarlato, V. Masignani, M. M. Giuliani, B. Arico, M. Comanducci, G. T. Jennings, L. Baldi, E. Bartolini, B. Capecchi, C. L. Galeotti, E. Luzzi, R. Manetti, E. Marchetti, M. Mora, S. Nuti, G. Ratti, L. Santini, S. Savino, M. Scarselli, E. Storni, P. Zuo, M. Broeker, E. Hundt, B. Knapp, E. Blair, T. Mason, H. Tettelin, D. W. Hood, A. C. Jeffries, N. J. Saunders, D. M. Granoff, J. C. Venter, E. R. Moxon, G. Grandi, and R. Rappuoli. 2000. Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science287:1816-1820.","journal-title":"Science"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00007-09"},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jmb.2008.12.005","volume":"386","year":"2009","unstructured":"Scarselli, M., F. Cantini, L. Santini, D. Veggi, S. Dragonetti, C. Donati, S. Savino, M. M. Giuliani, M. Comanducci, F. Di Marcello, G. Romagnoli, M. Pizza, L. Banci, and R. Rappuoli. 2009. Epitope mapping of a bactericidal monoclonal antibody against the factor H binding protein of Neisseria meningitidis. J. Mol. Biol.386:97-108.","journal-title":"J. Mol. Biol."},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/nature07769","volume":"458","year":"2009","unstructured":"Schneider, M. C., B. E. Prosser, J. J. Caesar, E. Kugelberg, S. Li, Q. Zhang, S. Quoraishi, J. E. Lovett, J. E. Deane, R. B. Sim, P. Roversi, S. Johnson, C. M. Tang, and S. M. Lea. 2009. Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates. Nature458:890-893.","journal-title":"Nature"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.01561-08"},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1084\/jem.183.1.307","volume":"183","year":"1996","unstructured":"Stoiber, H., C. Pinter, A. G. Siccardi, A. Clivio, and M. P. Dierich. 1996. Efficient destruction of human immunodeficiency virus in human serum by inhibiting the protective action of complement factor H and decay accelerating factor (DAF, CD55). J. Exp. Med.183:307-310.","journal-title":"J. Exp. Med."},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1574-6976.2006.00060.x","volume":"31","year":"2007","unstructured":"Trotter, C. L., M. Chandra, R. Cano, A. Larrauri, M. E. Ramsay, C. Brehony, K. A. Jolley, M. C. Maiden, S. Heuberger, and M. Frosch. 2007. A surveillance network for meningococcal disease in Europe. FEMS Microbiol. Rev.31:27-36.","journal-title":"FEMS Microbiol. Rev."},{"key":"e_1_3_2_29_2","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1086\/528994","volume":"197","year":"2008","unstructured":"Welsch, J. A., S. Ram, O. Koeberling, and D. M. Granoff. 2008. Complement-dependent synergistic bactericidal activity of antibodies against factor H-binding protein, a sparsely distributed meningococcal vaccine antigen. J. Infect. Dis.197:1053-1061.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_30_2","doi-asserted-by":"crossref","first-page":"5606","DOI":"10.4049\/jimmunol.172.9.5606","volume":"172","year":"2004","unstructured":"Welsch, J. A., R. Rossi, M. Comanducci, and D. M. Granoff. 2004. Protective activity of monoclonal antibodies to genome-derived neisserial antigen 1870, a Neisseria meningitidis candidate vaccine. J. Immunol.172:5606-5615.","journal-title":"J. Immunol."}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00103-10","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00103-10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T20:43:50Z","timestamp":1627591430000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.00103-10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["10.1128\/CVI.00103-10"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00103-10","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7]]},"assertion":[{"value":"2010-03-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2010-05-19","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}